BIT
ZYNE

BlackRock Institutional Trust’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

BlackRock Institutional Trust’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$364K Buy
23,346
+12,903
+124% +$174K ﹤0.01% 3506
2016
Q3 		$136K Hold
10,443
– – ﹤0.01% 3664
2016
Q2 		$72K Sell
10,443
-20,067
-66% -$168K ﹤0.01% 3742
2016
Q1 		$288K Sell
30,510
-1,989
-6% -$16K ﹤0.01% 3556
2015
Q4 		$327K Buy
32,499
+6,322
+24% +$83.7K ﹤0.01% 3575
2015
Q3 		$375K Buy
+26,177
New +$643K ﹤0.01% 3551

Other funds holding ZYNE

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock Institutional Trust's ZYNE Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Zynerba Pharmaceuticals, Inc (ZYNE) stake by 124% in Q4 2016, buying an estimated $174K and bringing the position to 23,346 shares worth $364K. The position accounts for ﹤0.01% of the portfolio, ranked #3506.

BlackRock Institutional Trust first reported a position in ZYNE in Q3 2015 and has held it in 6 quarters since. The position peaked at $375K in Q3 2015. 34 funds tracked by Wall St. Rank hold ZYNE as of Q4 2016.

  • BlackRock Institutional Trust held 23,346 shares of Zynerba Pharmaceuticals, Inc worth $364K as of Q4 2016.
  • BlackRock Institutional Trust bought 12,903 Zynerba Pharmaceuticals, Inc shares in Q4 2016, an estimated $174K.
  • Zynerba Pharmaceuticals, Inc made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3506 holding.
  • BlackRock Institutional Trust first reported a position in Zynerba Pharmaceuticals, Inc in Q3 2015 and has held it in 6 quarters since.
  • BlackRock Institutional Trust's Zynerba Pharmaceuticals, Inc position peaked at $375K in Q3 2015.
  • 34 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.